Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Current Leases (2019 - 2025)

China Pharma Holdings' Current Leases history spans 7 years, with the latest figure at $71628.0 for Q4 2025.

  • For Q4 2025, Current Leases rose 82.15% year-over-year to $71628.0; the TTM value through Dec 2025 reached $71628.0, up 82.15%, while the annual FY2025 figure was $71628.0, 82.15% up from the prior year.
  • Current Leases reached $71628.0 in Q4 2025 per CPHI's latest filing, up from $70326.0 in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $86672.0 in Q1 2022 to a low of $19776.0 in Q1 2025.
  • Average Current Leases over 5 years is $63959.1, with a median of $74850.0 recorded in 2023.
  • Peak YoY movement for Current Leases: plummeted 76.21% in 2023, then surged 279.71% in 2024.
  • A 5-year view of Current Leases shows it stood at $85282.0 in 2021, then crashed by 52.57% to $40445.0 in 2022, then soared by 92.18% to $77727.0 in 2023, then crashed by 49.41% to $39323.0 in 2024, then soared by 82.15% to $71628.0 in 2025.
  • Per Business Quant, the three most recent readings for CPHI's Current Leases are $71628.0 (Q4 2025), $70326.0 (Q3 2025), and $19776.0 (Q1 2025).